Vaccine effectiveness of primary and booster COVID-19 vaccinations against SARS-CoV-2 infection: Repeat analyses with updated data for the prospective cohort study in the Netherlands from July 2021 to June 2022

被引：0
|
作者：
Huiberts, Anne J. [1 ]
van de Hof, Susan [1 ]
Knol, Mirjam J. [1 ]
机构：
[1] Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control, Bilthoven, Netherlands
来源：
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES | 2024年 / 146卷
关键词：
D O I：
10.1016/j.ijid.2024.107127
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Vaccine effectiveness of primary and booster COVID-19 vaccinations against SARS-CoV-2 infection in the Netherlands from July 12, 2021 to June 6, 2022: A prospective cohort study
    Huiberts, Anne J.
    de Gier, Brechje
    Hoeve, Christina E.
    de Melker, Hester E.
    Hahne, Susan J. M.
    den Hartog, Gerco
    Grobbee, Diederick E.
    van de Wijgert, Janneke H. H. M.
    van den Hof, Susan
    Knol, Mirjam J.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2023, 133 : 36 - 42
  • [2] Homologous and Heterologous Covid-19 Booster Vaccinations Against SARS-CoV-2 Infection in the Elderly
    Acer, Omer
    Bahce, Yasemin Genc
    Ozudogru, Osman
    CURRENT MICROBIOLOGY, 2024, 81 (07)
  • [3] COVID-19 vaccine effectiveness against SARS-CoV-2 infection during the Delta period, a nationwide study adjusting for chance of exposure, the Netherlands, July to December 2021
    van Ewijk, Catharina E.
    Kooijman, Marjolein N.
    Fanoy, Ewout
    Raven, Stijn F. H.
    Middeldorp, Marit
    Shah, Anita
    de Gier, Brechje
    de Melker, Hester E.
    Hahne, Susan J. M.
    Knol, Mirjam J.
    EUROSURVEILLANCE, 2022, 27 (45)
  • [4] mRNA COVID-19 vaccine effectiveness against SARS-CoV-2 infection in a prospective community cohort, rural Wisconsin, November 2020 to December 2021
    McLean, Huong Q.
    McClure, David L.
    King, Jennifer P.
    Meece, Jennifer K.
    Pattinson, David
    Neumann, Gabriele
    Kawaoka, Yoshihiro
    Rolfes, Melissa A.
    Belongia, Edward A.
    INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2022, 16 (04) : 607 - 612
  • [5] Vaccine against COVID-19 or against SARS-CoV-2 infection?
    Rieske, Piotr
    ALERGOLOGIA POLSKA-POLISH JOURNAL OF ALLERGOLOGY, 2020, 7 (03) : 131 - 145
  • [6] Estimated COVID-19 vaccine effectiveness against seroconversion from SARS-CoV-2 Infection, March-October, 2021
    Plumb, Ian D.
    Fette, Lida M.
    Tjaden, Ashley H.
    Feldstein, Leora
    Saydah, Sharon
    Ahmed, Amina
    Link-Gelles, Ruth
    Wierzba, Thomas F.
    Berry, Andrea A.
    Friedman-Klabanoff, DeAnna
    Larsen, Moira P.
    Runyon, Michael S.
    Ward, Lori M.
    Santos, Roberto P.
    Ward, Johnathan
    Weintraub, William S.
    Edelstein, Sharon
    Uschner, Diane
    VACCINE, 2023, 41 (15) : 2596 - 2604
  • [7] Vaccine effectiveness against SARS-CoV-2 infection or COVID-19 hospitalization with the Alpha, Delta, or Omicron SARS-CoV-2 variant: A nationwide Danish cohort study
    Gram, Mie Agermose
    Emborg, Hanne-Dorthe
    Schelde, Astrid Blicher
    Friis, Nikolaj Ulrik
    Nielsen, Katrine Finderup
    Moustsen-Helms, Ida Rask
    Legarth, Rebecca
    Lam, Janni Uyen Hoa
    Chaine, Manon
    Malik, Aisha Zahoor
    Rasmussen, Morten
    Fonager, Jannik
    Sieber, Raphael Niklaus
    Stegger, Marc
    Ethelberg, Steen
    Valentiner-Branth, Palle
    Hansen, Christian Holm
    PLOS MEDICINE, 2022, 19 (09)
  • [8] Effectiveness of COVID-19 vaccine (Covaxin) against breakthrough SARS-CoV-2 infection in India
    Behera, Priyamadhaba
    Singh, Arvind Kumar
    Subba, Sonu Hangma
    Arjun, Mc
    Sahu, Dinesh Prasad
    Chandanshive, Pradnya Dilip
    Pradhan, Somen Kumar
    Parida, Swayam Pragyan
    Mishra, Abhisek
    Patro, Binod Kumar
    Batmanabane, Gitanjali
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2022, 18 (01)
  • [9] A Prospective Cohort Study of COVID-19 Vaccination, SARS-CoV-2 Infection, and Fertility
    Wesselink, Amelia K.
    Hatch, Elizabeth E.
    Rothman, Kenneth J.
    Wang, Tanran R.
    Willis, Mary D.
    Yland, Jennifer
    Crowe, Holly M.
    Geller, Ruth J.
    Willis, Sydney K.
    Perkins, Rebecca B.
    Regan, Annette K.
    Levinson, Jessica
    Mikkelsen, Ellen M.
    Wise, Lauren A.
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2022, 191 (08) : 1383 - 1395
  • [10] Rates of SARS-CoV-2 Breakthrough Infection or Severe COVID-19 and Associated Risk Factors After Primary and Booster Vaccination Against COVID-19 in the Netherlands
    van den Berg, Jesse M.
    Blom, Marieke T.
    Overbeek, Jetty A.
    Remmelzwaal, Sharon
    Herings, Ron M. C.
    Elders, Petra J. M.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 : 700 - 700
12345